Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201104332 Principal Investigator: Tabchy, Adel
Title: A Phase Ib/II, open label, multi-center study evaluating the safety and efficacy of BKM120 in combination with trastuzumab in patients with relapsing HER2 overexpressing breast cancer who have previously failed trastuzumab
Phase: I/II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to investigate new treatment options for patients with HER2 overexpressing locally advanced or metastatic breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)